---

What Makes This a 50-Mark Answer

Structure (6 major parts):

---

INFLAMMATION

Comprehensive Theory Answer - PG University Examination Standard

---

DEFINITION

1. Eliminate the causative agent
2. Remove necrotic cells and debris
3. Initiate tissue repair

---

CARDINAL SIGNS OF INFLAMMATION

---

TYPES OF INFLAMMATION

1. Acute inflammation - minutes to days; exudation of fluid and plasma proteins, neutrophil emigration
2. Chronic inflammation - weeks to months; mononuclear cell infiltration, tissue destruction and repair coexist
3. Granulomatous inflammation - special form of chronic inflammation; focal aggregates of activated macrophages

---

PART I: ACUTE INFLAMMATION

A. Definition and Components (Robbins & Cotran, 10th Ed.)

1. Dilation of small blood vessels (increased blood flow)
2. Increased permeability of the microvasculature (plasma protein and leukocyte extravasation)
3. Emigration and accumulation of leukocytes at the focus of injury

---

B. Vascular Reactions

1. Changes in Vascular Flow and Caliber

• Vasodilation: Induced by histamine and nitric oxide acting on vascular smooth muscle. Affects mainly postcapillary venules. Results in increased blood flow = heat (calor) and redness (rubor). One of the earliest manifestations.
• Stasis: Loss of fluid and vascular dilatation leads to slower flow; RBCs concentrate in small vessels (vascular congestion); leukocytes accumulate peripherally along the endothelium (margination).

2. Increased Vascular Permeability

• Endothelial cell contraction forming intercellular gaps - most common; induced by histamine, bradykinin, leukotrienes, substance P; affects postcapillary venules; reversible and immediate
• Endothelial injury (direct vascular damage from burns, toxins) - may be immediate/sustained or delayed/prolonged
• Leukocyte-mediated vascular injury - activated leukocytes release ROS and proteolytic enzymes
• Transcytosis - vesicular transport across endothelial cells (VEGF-induced)
• Angiogenesis - new vessel growth with inherently leaky walls

3. Exudate vs. Transudate

---

C. Leukocyte Recruitment (Cellular Events)

Step 1: Margination

Step 2: Rolling

• Mediated by selectins (low-affinity, reversible binding)
• P-selectin and E-selectin on endothelium; L-selectin on leukocytes
• Ligands: PSGL-1 and sialyl-Lewis X on leukocytes
• Results in characteristic rolling movement along the endothelium

Step 3: Firm Adhesion

• Mediated by integrins on leukocyte surface (high-affinity)
• LFA-1 (CD11a/CD18) binds ICAM-1 on endothelium
• VLA-4 binds VCAM-1 on endothelium
• Chemokines (IL-8/CXCL8) activate integrins, increasing avidity
• TNF and IL-1 upregulate integrin ligands on endothelium

Step 4: Transmigration (Diapedesis)

• Leukocytes squeeze through interendothelial junctions
• PECAM-1 (CD31) is critical for this step
• Neutrophils predominate first (6-24 hours); monocytes predominate later (24-48 hours onward)

Step 5: Chemotaxis

• Exogenous: bacterial products (N-formyl methionine peptides, fMLP)
• Endogenous: C5a, LTB4, IL-8/CXCL8, PAF

---

D. Leukocyte Activation and Phagocytosis

Activation via Pattern Recognition Receptors:

• Toll-like receptors (TLRs): Recognize PAMPs; signaling through NF-κB leads to cytokine production
• NOD-like receptors (NLRs): Intracellular receptors; form inflammasome → activates caspase-1 → cleaves pro-IL-1β to active IL-1β
• G protein-coupled receptors responding to chemokines
• Cytokine receptors (TNF, IL-1)

Phagocytosis (Three Steps):

• IgG (Fc region) binds Fc receptors (FcγRI, FcγRII, FcγRIII) on leukocytes
• C3b binds CR1/CR3 (complement receptors) on leukocytes
• Opsonization dramatically increases phagocytic efficiency

• Pseudopod extension around the particle
• Phagosome formation → fusion with lysosome → phagolysosome

• Respiratory burst: NADPH oxidase → Superoxide (O2•-) → H2O2 → HOCl (hypochlorous acid) via myeloperoxidase (MPO) system
• Defect: Chronic Granulomatous Disease (CGD) - NADPH oxidase deficiency → recurrent catalase-positive organism infections

• Lysozyme - degrades bacterial cell wall peptidoglycan
• Defensins - antimicrobial peptides
• Lactoferrin - sequesters iron
• Major basic protein (eosinophils)
• Bactericidal/permeability-increasing protein (BPI)

Neutrophil Extracellular Traps (NETs):

• Networks of nuclear chromatin + granule enzymes extruded from neutrophils
• Trap and kill microorganisms extracellularly
• Can cause vascular damage in sepsis and thrombosis

---

E. Chemical Mediators of Inflammation

Key Mediators Table:

Arachidonic Acid Pathway (Critical):

Membrane Phospholipids
         |
         | (Phospholipase A2)
         | BLOCKED BY CORTICOSTEROIDS (via lipocortin)
         |
   Arachidonic Acid
      /                      \
COX pathway              5-LOX pathway
(Cyclooxygenase)         (5-Lipoxygenase)
BLOCKED BY NSAIDs/Aspirin    BLOCKED BY Zileuton
      |                           |
Prostaglandins              LTA4
Thromboxanes                 /        \
Prostacyclin             LTB4     LTC4, LTD4, LTE4
                      (chemotaxis)  (bronchoconstriction)
                                    BLOCKED by Montelukast
                   Also: Lipoxins (anti-inflammatory)

Complement Pathways:

• Classical: Antibody (IgM or IgG) + antigen → C1 activation
• Lectin: MBL binds microbial carbohydrates → MASP activation
• Alternative: Spontaneous C3 hydrolysis stabilized by microbial surfaces

---

F. Morphologic Patterns of Acute Inflammation

1. Serous Inflammation

• Watery, cell-poor fluid; few leukocytes
• Examples: pleural effusion, skin blisters (burns, herpes zoster)

2. Fibrinous Inflammation

• Large amounts of fibrin due to greater vascular permeability
• Classic example: "Bread and butter" pericarditis (fibrinous pericarditis)
• If fibrin not cleared → organization → fibrous scar (constrictive pericarditis)

3. Suppurative (Purulent) Inflammation

• Pus = neutrophils + liquefied necrotic debris + edema fluid
• Caused by pyogenic bacteria (staphylococci, streptococci)
• Abscess: localized collection of pus; central liquefied zone + surrounding neutrophils + peripheral granulation tissue wall

4. Ulceration

• Local defect produced by shedding of inflamed necrotic tissue
• Examples: peptic ulcer, aphthous ulcers, periodontal pocket ulceration

---

G. Outcomes of Acute Inflammation

1. Complete Resolution

• Normal outcome when injury is limited and tissue can regenerate
• Clearance of debris by macrophages; resorption of edema by lymphatics; tissue regeneration

2. Healing by Connective Tissue Replacement (Fibrosis/Scarring)

• Occurs when tissue destruction is substantial or tissue cannot regenerate
• Fibrous tissue replaces damaged area = organization

3. Progression to Chronic Inflammation

• When acute response cannot be resolved due to persistence of injurious agent

---

H. Systemic Effects (Acute Phase Response)

1. Fever

• Exogenous pyrogens (LPS) → endogenous pyrogens (IL-1, TNF) → hypothalamus → upregulate COX → PGE2 → resets thermostat higher
• NSAIDs block fever by inhibiting COX/PGE2 synthesis

2. Leukocytosis

• Neutrophilia - bacterial infections; "shift to the left"
• Lymphocytosis - viral infections (EBV, mumps)
• Eosinophilia - parasitic infections, allergic reactions
• Leukopenia - typhoid fever, rickettsial infections

3. Acute Phase Proteins (synthesized by liver, stimulated by IL-6)

• C-reactive protein (CRP): opsonin; fixes complement; most sensitive inflammation marker
• Fibrinogen: rouleaux formation → elevated ESR; substrate for fibrin
• Serum Amyloid A (SAA): precursor of AA amyloid in chronic states
• Hepcidin: reduces iron → anemia of chronic disease
• Thrombopoietin: elevated → thrombocytosis

4. Septic Shock

• Massive bacteremia → TNF, IL-1 flood → DIC + hypotensive shock + metabolic disturbances (insulin resistance, hyperglycemia)
• = Systemic inflammatory response syndrome (SIRS)

---

PART II: CHRONIC INFLAMMATION

A. Definition

---

B. Causes

1. Persistent infections - mycobacteria (TB, leprosy), fungi, parasites, certain viruses; often evoke delayed-type hypersensitivity
2. Hypersensitivity/autoimmune diseases - rheumatoid arthritis, multiple sclerosis, IBD, Hashimoto thyroiditis, SLE; allergic diseases (bronchial asthma)
3. Prolonged exposure to toxic agents - exogenous (silica → silicosis) or endogenous (cholesterol → atherosclerosis)

---

C. Morphologic Features (Three Hallmarks)

1. Infiltration with mononuclear cells - macrophages, lymphocytes, plasma cells
2. Tissue destruction induced by persistent offending agent or inflammatory cells
3. Attempts at healing via angiogenesis + fibrosis

---

D. Cells of Chronic Inflammation

1. Macrophages (Dominant Cells)

• Derived from blood monocytes; tissue half-life: months to years
• Tissue-resident forms: Kupffer cells (liver), microglia (CNS), alveolar macrophages, osteoclasts

2. Lymphocytes

• Th1: Produce IFN-γ → classically activate macrophages (M1) - most important for intracellular pathogens and autoimmunity
• Th2: Produce IL-4, IL-5, IL-13 → eosinophil recruitment + IgE production + alternative macrophage activation (M2)
• Th17: Produce IL-17 → neutrophil and monocyte recruitment; important in autoimmune diseases

• Macrophages present antigen + secrete IL-12 → activate T cells
• Activated T cells secrete IFN-γ → further activate macrophages
• This amplification loop drives the chronicity of inflammation

3. Other Cells

• Eosinophils: Parasitic infections, allergic reactions; contain major basic protein (toxic to helminths); recruited by eotaxin/CCL11
• Mast cells: Express FcεRI (IgE receptor); central in immediate hypersensitivity; secrete cytokines in chronic reactions
• Plasma cells: Immunoglobulin production; predominate in Stage 3-4 periodontal lesions
• Neutrophils: Persist in some chronic infections - osteomyelitis ("acute on chronic")

---

E. Systemic Effects of Chronic Inflammation

• Amyloidosis (AA type) - sustained SAA production → AA amyloid deposition in kidney, liver, spleen
• Anemia of chronic disease - hepcidin → iron sequestration → reduced erythropoiesis
• Cancer risk - chronic inflammation creates pro-tumorigenic microenvironment:
  • H. pylori → gastric carcinoma
  • HBV/HCV → hepatocellular carcinoma
  • Crohn disease → colorectal cancer
  • Asbestos/silica → mesothelioma/lung cancer

---

PART III: GRANULOMATOUS INFLAMMATION

A. Definition

---

B. Types

---

C. Morphology

• Epithelioid cells: Activated macrophages with abundant pink granular cytoplasm, indistinct cell borders; resemble epithelial cells
• Langhans giant cells: 40-50 μm; fusion of activated macrophages; nuclei arranged in horseshoe/peripheral pattern - characteristic of TB
• Foreign body giant cells: Same size but nuclei scattered randomly
• Lymphocyte cuff surrounding the epithelioid cell aggregate
• Older granulomas: rim of fibroblasts and connective tissue
• Caseous necrosis: Central amorphous, structureless, eosinophilic granular debris (complete loss of cellular architecture) - characteristic of TB; caused by hypoxia + free radical injury

---

D. Common Causes

---

PART IV: TISSUE REPAIR AND HEALING

A. Overview

1. Regeneration - replacement with normal cells
2. Scar formation - connective tissue deposition ("patches" rather than restores)

---

B. Cell Proliferative Capacity

---

C. Steps in Scar Formation

1. Hemostasis - platelet plug + fibrin clot; scaffold for cell migration
2. Inflammation (hours - 2 days) - neutrophils then macrophages clear the wound
3. Cell proliferation (days 3-10):
   • Epithelial cells migrate and cover wound
   • Endothelial cells + pericytes proliferate → angiogenesis
   • Fibroblasts proliferate and migrate → lay down collagen
4. Granulation tissue formation - new capillaries + fibroblasts + loose ECM; pink, soft, granular gross appearance
5. Connective tissue deposition - gradual collagen deposition replacing granulation tissue → stable fibrous scar
6. ECM Remodeling - MMPs remodel collagen; TIMPs inhibit MMPs; balance determines scar quality

• TGF-β - most important fibrogenic agent; stimulates fibroblast migration/proliferation + collagen synthesis; inhibits MMPs
• PDGF - recruits fibroblasts and smooth muscle cells
• VEGF - stimulates angiogenesis
• FGF-2 - proliferation of endothelial cells and fibroblasts
• M2 macrophages - dominant pro-repair cell type; secrete TGF-β, IL-10, growth factors

---

D. Wound Healing

First Intention (Primary Union):

• Day 1: Neutrophils, fibrin clot; epithelial cells begin migrating
• Day 3: Macrophages replace neutrophils; granulation tissue begins
• Day 5: Peak neovascularization; granulation tissue fills space
• Week 2: Collagen accumulation; decreased inflammation
• Month 1: Scar; tensile strength improves
• Wound strength reaches 70-80% of normal by 3 months (never reaches 100%)

Second Intention (Secondary Union):

• Large tissue defect; more intense inflammation; larger granulation tissue
• Wound contraction by myofibroblasts (modified fibroblasts with actin filaments)
• Within 6 weeks: defect reduced to 5-10% of original size by contraction

---

E. Factors Affecting Healing

---

F. Abnormalities of Healing

• Hypertrophic scar: Excessive collagen within wound boundaries; abundant myofibroblasts; may regress
• Keloid: Scar grows beyond wound boundaries; does not regress; more common in African Americans
• Contracture: Exaggerated wound contraction → deformity; common after burns; limits joint movement
• Chronic wounds: Venous leg ulcers, arterial ulcers, diabetic ulcers, pressure sores

---

PART V: WRITE NOTE - INFLAMMATION IN PERIODONTOLOGY

Introduction

---

Microbiology and Initiating Stimulus

• Healthy sites: Facultative gram-positive organisms (Streptococcus, Actinomyces)
• Active periodontitis: Shift to anaerobic gram-negative flora (dysbiosis)

Key Periodontal Pathogens:

---

Pathogenesis: Page and Schroeder Classification

Stage 1 - Initial Lesion (2-4 days):

• Acute vascular response; increased vascular permeability
• Exudation of gingival crevicular fluid (GCF)
• PMNs (neutrophils) predominate in junctional epithelium and sulcus
• Subclinical; reversible

Stage 2 - Early Lesion (4-7 days):

• Transition to chronic infiltrate
• Predominantly T-lymphocytes in connective tissue
• Collagen loss begins subjacent to junctional epithelium
• Altered fibroblast morphology (vacuolated/damaged)
• Clinically apparent gingivitis; reversible

Stage 3 - Established Lesion (weeks to months):

• Plasma cells and B-lymphocytes predominate (T → B cell shift)
• Dense infiltrate; active immunoglobulin production
• Junctional epithelium begins apical migration (pocket formation begins)
• Collagen loss extends laterally
• Chronic gingivitis - potentially reversible with plaque removal

Stage 4 - Advanced Lesion:

• Periodontitis proper; irreversible tissue destruction
• True periodontal pocket (JE migrates apically below CEJ)
• Alveolar bone resorption via osteoclast activation
• Destruction of principal periodontal ligament fibers
• IRREVERSIBLE without treatment

---

Mechanisms of Tissue Destruction

1. Direct Bacterial Mechanisms:

• Bacterial enzymes (collagenases, proteases, hyaluronidase) destroy connective tissue
• LPS of gram-negative organisms activates TLR-4, complement, cytokine release
• P. gingivalis gingipains cleave C3, C5, and immunoglobulins → evade host defense

2. Host-Mediated Destruction (Dominant Mechanism):

• IL-1β and TNF-α: Key drivers of alveolar bone loss; stimulate PGE2 production and RANKL upregulation
• IL-6: Elevated in GCF and serum; promotes osteoclast differentiation
• IL-17 (Th17): Promotes neutrophil recruitment; neutrophil-mediated tissue damage

• Produced by macrophages and fibroblasts
• Major mediator of alveolar bone resorption
• Stimulates osteoclastogenesis via RANKL upregulation
• GCF PGE2 levels correlate with disease severity

• MMP-8 (PMN-collagenase) - dominant collagenase in GCF; degrades type I/III collagen
• MMP-1, MMP-13 - additional collagenases from macrophages/fibroblasts
• MMP-2, MMP-9 - gelatinases degrade denatured collagen and basement membranes
• Elevated in GCF of periodontitis patients

Inflammatory mediators
(IL-1β, TNF-α, PGE2, IL-17)
         |
         ↓ Upregulate
      RANKL (on stromal cells, osteoblasts, T cells)
         |
         ↓ Binds RANK on osteoclast precursors
    Osteoclast differentiation + activation
         |
         ↓
    ALVEOLAR BONE RESORPTION

OPG (osteoprotegerin) = decoy receptor
↓ OPG in periodontitis
↑ RANKL:OPG ratio = net bone loss

• Generated by PMNs during respiratory burst
• Tissue damage when released extracellularly
• Contributes to collagen degradation and lipid peroxidation

• C3a and C5a increase vascular permeability; recruit more PMNs
• P. gingivalis aberrantly activates complement → amplification loop worsening destruction

3. Pattern of Bone Loss:

• Horizontal bone loss: Generalized, uniform loss of alveolar crest; common in chronic periodontitis
• Vertical (angular) bone loss: Localized, angular defects; associated with aggressive/localized disease; 1-wall, 2-wall, 3-wall bony defects

---

Histological Features of Advanced Periodontitis (Stage 4)

• Ulceration of pocket epithelium (non-keratinized sulcular epithelium)
• Dense infiltrate of plasma cells and lymphocytes in connective tissue
• Dilated capillaries, tissue edema
• Loss of principal periodontal ligament fibers
• Howship's lacunae (resorption lacunae) with osteoclasts at alveolar bone margin
• Deepened pocket with apically migrated junctional epithelium

---

Gingivitis vs. Periodontitis

---

Systemic Associations of Periodontitis

---

Treatment Implications Based on Inflammatory Pathogenesis

---

PART VI: SUMMARY COMPARISON TABLE

---

CLINICAL CORRELATIONS (PG Exam High-Yield)

• CGD (Chronic Granulomatous Disease): NADPH oxidase deficiency; recurrent infections with catalase-positive organisms (Staph., Aspergillus); granuloma formation due to inability to kill phagocytosed bacteria
• LAD (Leukocyte Adhesion Deficiency): CD18/β2-integrin deficiency; failure of leukocyte transmigration; recurrent bacterial infections; no pus; delayed umbilical cord separation
• C3 deficiency: Susceptibility to encapsulated bacteria; no opsonization
• COX-2 selective inhibitors (celecoxib): May increase cardiovascular risk - blocks PGI2 (prostacyclin, vasodilator) but spares TXA2 (vasoconstrictor) → tips balance toward thrombosis
• Aspirin irreversibly acetylates COX → permanent inhibition in platelets (no nucleus = no new COX); basis of low-dose aspirin anti-thrombotic use
• Steroids block phospholipase A2 (via lipocortin) → block the entire arachidonic acid cascade (both COX and LOX pathways)

---

• Robbins & Cotran Pathologic Basis of Disease, 10th Ed., Chapter 3: Inflammation and Repair
• Review of Pathology & Genetics, 10th Ed.

---

Quick Guide: What to Write in Exam (Time Allocation for 50 Marks)

---

COMPLETE ABBREVIATION GLOSSARY

For the 50-Mark Inflammation Answer

---

A

---

B

---

C

---

D

---

E

---

F

---

G

---

H

---

I

---

J

---

L

---

M

---

N

---

O

---

P

---

R

---

S

---

T

---

V

---

Z

---

Quick Reference: Key Pathways Expanded

---